Intersect ENT
XENT
$28.24
Share price
0.00%
Change (1 day)
17.72%
Change (1 year)
Categories
P/S ratio for Intersect ENT (XENT)
P/S ratio at the end of 2021: 8.56
According to Intersect ENT's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is . At the end of 2021 the company had a P/S ratio of 8.56.
P/S ratio history for Intersect ENT from 2014 to 2021
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2021 | 8.56 | -8.57% |
| 2020 | 9.36 | 27.32% |
| 2019 | 7.35 | -7.93% |
| 2018 | 7.99 | -19.4% |
| 2017 | 9.91 | 125.68% |
| 2016 | 4.39 | -57.31% |
| 2015 | 10.3 | -8.48% |
| 2014 | 11.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Ocular Therapeutix OCUL | 16.6 | N/A | 🇺🇸 USA |
 ICON plc ICLR | 3.17 | N/A | 🇮🇪 Ireland |
 Anika Therapeutics ANIK | 2.27 | N/A | 🇺🇸 USA |
 Haemonetics HAE | 3.79 | N/A | 🇺🇸 USA |